Functionally, in vivo and in vitro experiments demonstrate that high methylation levels can overexpress EBF3, promote CNTNAP4 transcription expression, ameliorate PD behavioral deficits, and inhibit dopamine neuron apoptosis. The gene discussed is EBF3; the disease is Parkinson disease.